Connection between Breast and Ovarian Cancer: Identified Linkages and Risk Factors
Title: Shared Risk Factors and Genetic Mutations Link Breast and Ovarian Cancer
A well-established genetic link underpins the association between breast cancer and ovarian cancer. Particularly relevant for individuals carrying mutations in the BRCA1 and BRCA2 genes, these cancer types share risk factors that may increase the likelihood of both.
Both breast and ovarian cancer can be influenced by common shared risk factors such as older age, being overweight or obese, and never carrying a pregnancy to term. Managing some of these risks, such as maintaining a healthy weight, may reduce the potential for developing either cancer.
It is worth noting that people who have had breast cancer may have an elevated risk of developing ovarian cancer, with research indicating a nearly two-fold increase in subsequent primary ovarian cancer. Conversely, ovarian cancer may increase the propensity for breast cancer, although this risk varies over time following the initial cancer diagnosis.
Genetic mutations play a crucial role in this link, with the presence of BRCA1 or BRCA2 mutations significantly raising the risk of both breast and ovarian cancer in affected individuals. Nearly 60% of families with a history of ovarian and breast cancer have a BRCA1 gene mutation, while approximately 20% have a BRCA2 mutation.
Beyond these key genetic factors, various other shared risk factors for breast and ovarian cancer may include:
- A family history of either cancer
- Aging, with ovarian cancer more prevalent in individuals over 40 years, and breast cancer in those aged 55 or older
- Being overweight or obese
- Having a first child later in life
- Never having children
- Not breastfeeding
- Hormone therapy after menopause
By managing unchangeable risk factors, as well as making lifestyle changes and seeking preventive medical procedures when necessary, people who have had either breast or ovarian cancer can reduce their risk of a recurrence or developing another type of cancer.
Genetic testing for BRCA1, BRCA2, and other relevant mutations is essential to monitor and prevent both cancers in those at higher risk. For individuals carrying genetic mutations, prophylactic surgical procedures such as organ removal may be considered to prevent occurrence or spread of cancer.
On the other hand, modifiable risk factors such as maintaining a moderate weight, regular exercise, limiting alcohol consumption, and controlling hormonal factors can potentially reduce the risk of both breast and ovarian cancer.
A 2020 observational study suggests people with both primary breast cancer and primary ovarian cancer have a relatively favorable outlook, with 5- and 10-year overall survival rates approaching 90%. The outlook is generally more positive when the time between the two cancers is longer, although ovarian cancer following breast cancer often stages earlier, affecting survival. A person's age during their first cancer diagnosis and the time between the two cancers are significant predictors of overall survival.
Individuals are advised to speak with a doctor if signs or symptoms of breast or ovarian cancer arise, particularly given a personal or family history of these diseases. Given the importance of early detection and prompt treatment, vigilance for signs of recurrence or a second cancer after a previous diagnosis is essential.
For additional evidence-based information and cancer resources, visit our dedicated hub.
FAQs
People with ovarian cancer may have an increased risk of several other cancers, including bladder cancer, bile duct cancer, colorectal cancer, acute leukemia, and melanoma of the eye.
Breast cancer can metastasize (spread) to the ovaries, although this is relatively uncommon and may be more likely in cases of advanced breast cancer or hormone receptor-positive cancers.
At-risk groups for ovarian cancer may include:
- Individuals with BRCA1 or BRCA2 gene mutations
- Those with a family history of ovarian, breast, or colorectal cancer
- People with Lynch syndrome
- Those with endometriosis
- Those who have never been pregnant
- Those who had a late first pregnancy
- Women over 40 years of age
In summary, due to shared genetic mutations, particularly in the BRCA1 and BRCA2 genes, there is a strong association between breast cancer and ovarian cancer. Genetic testing, regular screenings, and preventive measures are essential for managing and reducing the risks in individuals at higher risk.
- People who carry mutations in the BRCA1 and BRCA2 genes are at higher risk for both breast and ovarian cancer.
- Shared risk factors for breast and ovarian cancer include older age, being overweight or obese, and never carrying a pregnancy to term.
- Managing these risks, such as maintaining a healthy weight, may help reduce the potential for developing either cancer.
- Having had breast cancer increases the risk of developing ovarian cancer, with a nearly two-fold increase in the likelihood of subsequent primary ovarian cancer.
- Beyond BRCA1 and BRCA2 mutations, a family history of either cancer, aging, hormone therapy after menopause, and not breastfeeding are also shared risk factors for both breast and ovarian cancer.
- Modifying risk factors like maintaining a moderate weight, regular exercise, limiting alcohol consumption, and controlling hormonal factors can potentially reduce the risk of both breast and ovarian cancer.
